Wyeth v. Levine

555 U.S. 555·2009

What the Court Decided

The Supreme Court held that state law failure-to-warn claims regarding pharmaceuticals were not preempted by federal FDA approval of drug labeling, because the FDA's approval set a minimum standard and did not occupy the field of warning adequacy.

Full entry not yet generated. Run npm run enrich-precedents to add it.

Cited In

Monsanto Company v. John L. Durnell

2025 Term · 24-1068

Wyeth is cited by respondent for the principle that FDA approval of drug labeling does not preempt state failure-to-warn claims, providing an analogue to FIFRA preemption analysis.